The primary objective of these guidelines was to provide general clinicians with information
that would guide them to make informed choices from the available diagnosis/treatment …

In this review, we focused on four topics, namely, minimally invasive esophagectomy (MIE),
robot‐assisted minimally invasive esophagectomy (RAMIE), conversion and salvage …

Definitive chemoradiotherapy (dCRT) for the esophageal squamous cell carcinoma (ESCC)
is performed for patients with cT4 disease without distant metastasis and also for those with …

Background Although definitive chemoradiotherapy (CRT) is recommended for patients with
locally advanced unresectable esophageal cancer, the outcome is unsatisfactory. We …

Purpose The management of cT4b thoracic esophageal cancer (EC) is challenging. The
optimal treatment remains unclear, and prospective or large-scale retrospective reports on …

Background Patients with esophageal cancer that invades adjacent structures (cT4b) are
precluded from surgery and usually treated with definitive chemoradiotherapy (dCRT). dCRT …

Background Standard treatment for unresectable locally advanced esophageal cancer is
definitive chemoradiotherapy (dCRT). Although salvage esophagectomy is the only curative …

Background The optimal treatment approach for T4 esophageal cancer is not well
established. We aimed to perform a systematic review and meta-analysis to determine the …

Simple Summary The rates of adverse events and incomplete treatment remain high among
patients with unresectable or metastatic esophageal cancer who receive definitive treatment …

Background Salvage esophagectomy for residual tumor and localized relapses after
definitive chemoradiotherapy (dCRT) for patients with esophageal cancer is associated with …